Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights January -- March 2017.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 5, p. 327, doi. 10.1177/0018578717715385
- Publication type:
- Article
Works matching IS 00185787 AND DT 2017 AND VI 52 AND IP 5
Results: 12
1
2
Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals.
- Published in:
- 2017
- Publication type:
- Chart/Diagram/Graph
3
Insulin Degludec/Liraglutide.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 5, p. 374, doi. 10.1177/0018578717715383
- By:
- Publication type:
- Article
4
Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 5, p. 367, doi. 10.1177/0018578717715382
- By:
- Publication type:
- Article
5
Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 5, p. 361, doi. 10.1177/0018578717715364
- By:
- Publication type:
- Article
6
Pharmacists' Knowledge of the Cost of Laboratory Testing.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 5, p. 357, doi. 10.1177/0018578717715357
- By:
- Publication type:
- Article
7
For Sale: FDA Priority Review Vouchers.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 5, p. 324, doi. 10.1177/0018578717715330
- By:
- Publication type:
- Article
8
Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 5, p. 348, doi. 10.1177/0018578717715355
- By:
- Publication type:
- Article
9
Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 5, p. 341, doi. 10.1177/0018578717715353
- By:
- Publication type:
- Article
10
Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 5, p. 334, doi. 10.1177/0018578717715352
- By:
- Publication type:
- Article
11
ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced Cholestatic Hepatitis Decitabine-Induced Hand and Foot Syndrome.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 5, p. 330, doi. 10.1177/0018578717715349
- By:
- Publication type:
- Article
12
Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention.
- Published in:
- Hospital Pharmacy, 2017, v. 52, n. 5, p. 353, doi. 10.1177/0018578717715356
- By:
- Publication type:
- Article